About
Vyome Holdings, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
Apr 6 2026
Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
Mar 26 2026
Vyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase
Feb 24 2026
Livechain Completes Acquisition of Senior, Secured Debt of Humanyze, An MIT Incubated, AI Enabled HR Analytics Company
Feb 18 2026
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
Recent Videos

US stock HIND analysis
Apr 24, 2026

Vyome Podar’s Big Win 🚀 | Into Babson for Entrepreneurship!
Apr 05, 2026

2026-01-27 08:02:07 HIND Level 2 and Time & Sales
Apr 04, 2026

My Key VT-1953 Insight from Vyome Holdings' 8-K
Feb 14, 2026
Google Übersetzer